MedPath

广州市联瑞制药有限公司

Ownership
-
Established
2012-02-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20254295
Approval Date
May 27, 2025
NMPA

Carbocysteine Oral Solution

Product Name
羧甲司坦口服溶液
Approval Number
国药准字H20254265
Approval Date
May 27, 2025
NMPA

Perindopril Arginine and Amlodipine Besylate Tablets (Ⅲ)

Product Name
培哚普利氨氯地平片(Ⅲ)
Approval Number
国药准字H20249535
Approval Date
Dec 1, 2024
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20247138
Approval Date
Jun 26, 2024
NMPA

Clindamycin Palmitate Hydrochloride Granules

Product Name
盐酸克林霉素棕榈酸酯颗粒
Approval Number
国药准字H20163212
Approval Date
May 14, 2024
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20234080
Approval Date
Dec 29, 2023
NMPA

Epinastine Hydrochloride Tablets

Product Name
盐酸依匹斯汀片
Approval Number
国药准字H20223745
Approval Date
Oct 11, 2022
NMPA

Epinastine Hydrochloride Tablets

Product Name
盐酸依匹斯汀片
Approval Number
国药准字H20223744
Approval Date
Oct 11, 2022
NMPA

Epinastine Hydrochloride Granules

Product Name
盐酸依匹斯汀颗粒
Approval Number
国药准字H20213886
Approval Date
Nov 24, 2021
NMPA

Epinastine Hydrochloride Granules

Product Name
盐酸依匹斯汀颗粒
Approval Number
国药准字H20213885
Approval Date
Nov 24, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.